Bayer Rises as BofAML Predicts New Drug Success: Frankfurt Mover
Bayer Rises as BofAML Predicts New Drug Success: Frankfurt Mover
Filed under: drug rehab treatment programs
Bayer made progress last year with blood thinner Xarelto, eye drug Eylea, lung treatment riociguat, colorectal cancer medicine Stivarga and prostate cancer drug Alpharadin. The company gave its peak annual sales forecast of 5.5 billion euros for the …
Read more on Bloomberg
Geron Corporation's Recent Catalysts
Filed under: drug rehab treatment programs
Last month on December 10th, the company reported early clinical trial results for its drug imetelstat as a treatment for a blood platelet disorder. Geron said 100 percent of patients responded to the drug, and most patients who had a specific gene …
Read more on Seeking Alpha
Researchers study innovative stem cell drug for treating localized cartilage …
Filed under: drug rehab treatment programs
Treating cartilage damage can be problematic because the tissue does not contain blood vessels or nerves and therefore has a limited ability to re-grow. Various treatments for cartilage degeneration, such as drug therapy, arthroscopy and joint …
Read more on News-Medical.net